May 21, 2013
From novel research to innovative medicines: GSK launches Discovery Fast Track competition for academic researchers
May 10, 2013
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
May 07, 2013
GSK gives update on plans to share detailed clinical trial data as part of its commitment to transparency
May 01, 2013
Regulatory update: Trametinib US PDUFA date extended to 3 September 2013
April 30, 2013
GSK announces regulatory submission for umeclidinium monotherapy in US
April 29, 2013
GlaxoSmithKline and Impax Pharmaceuticals terminate their collaboration on IPX066
April 22, 2013
GSK and Theravance announce regulatory submission for ANORO™ ELLIPTA™ (UMEC/VI) in Japan
April 17, 2013
FDA Advisory Committee recommends approval of BREO(TM) ELLIPTA(TM) for the treatment of COPD
April 17, 2013
GlaxoSmithKline, Triangle Community Foundation Issue Call for Applications Totaling $400,000 in GSK IMPACT Awards
April 17, 2013
GlaxoSmithKline Issues Call for Applications Totaling $400,000 in GSK IMPACT Awards
April 05, 2013
GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
April 03, 2013
GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab ) in patients with vasculitis
March 26, 2013
Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas
March 20, 2013
GSK publishes 2012 Corporate Responsibility report
March 07, 2013
Regulatory update – GSK announces regulatory submission for albiglutide in Europe
March 06, 2013
Americans Rate Themselves and Their Communities as Healthy, Despite Research Showing the Opposite
February 27, 2013
ViiV Healthcare announces a voluntary licence agreement with the Medicines Patent Pool to increase access to HIV medicines for children
February 06, 2013
Results announcement for the fourth quarter 2012
February 06, 2013
GlaxoSmithKline progresses multi-city discussion focused on improving the health of US communities
February 05, 2013
GSK announces support for AllTrials campaign for clinical trial transparency
February 05, 2013
GSK increases stake in its publicly-listed Consumer Healthcare subsidiary in India to 72.5 per cent
January 28, 2013
GSK and Biological E. announce joint venture to develop combination vaccine for India and other developing countries
January 24, 2013
GSK appoints Mr Hans Wijers to its Board as a Non-Executive Director
January 14, 2013
Regulatory update – GSK announces submission of albiglutide BLA to the US FDA for the treatment of type 2 diabetes
December 20, 2012
GlaxoSmithKline and Amicus Therapeutics announce top-line six-month primary treatment period results from first Phase III Fabry monotherapy study
December 14, 2012
GSK receives FDA approval for raxibacumab anti-toxin for the treatment of inhalational anthrax
December 12, 2012
GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
December 10, 2012
GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique
November 28, 2012
GSK welcomes the publication of the 2012 Access to Medicines Index
November 26, 2012
GSK initiates voluntary open offer to increase stake in its publicly-listed Consumer Healthcare subsidiary in India
November 26, 2012
GSK announces agreement in principle to increase its stake in GlaxoSmithKline Consumer Nigeria PLC
November 19, 2012
FDA approves new indication for PROMACTA® (eltrombopag)
November 14, 2012
GlaxoSmithKline announces vote from FDA advisory committee to recommend approval of H5N1 influenza vaccine candidate
November 09, 2012
RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants
November 08, 2012
GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Award
November 08, 2012
GlaxoSmithKline and XenoPort mutually agree to terminate their collaboration on Horizant
November 02, 2012
GSK announces FDA Advisory Committee vote in favour of raxibacumab for the treatment of inhalational anthrax infection
October 31, 2012
GSK supports BMJ commitment on clinical trial data transparency
October 31, 2012
Results announcement for the third quarter 2012
October 29, 2012
GSK announces start of Phase lll programme for mepolizumab in severe refractory asthma
October 29, 2012
Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio
October 24, 2012
GlaxoSmithKline Launches New Program to Help Consumers Recycle Empty GSK Respiratory Inhalers
October 22, 2012
Results from five phase III studies presented for GSK’s two candidate quadrivalent influenza vaccines
October 11, 2012
GSK announces further initiatives to advance openness and collaboration to help tackle global health challenges
October 09, 2012
Millions of children in Pakistan to be protected against pneumococcal disease with GSK’s Synflorix
October 04, 2012
Shionogi-ViiV Healthcare announces completion of initial clinical registration package for dolutegravir in HIV
September 26, 2012
GlaxoSmithKline plc announces changes to its Board and Committees
September 26, 2012
GSK and Theravance announce FDA acceptance of FF/VI New Drug Application (NDA) submission in the US for COPD
September 24, 2012
GlaxoSmithKline initiates a multi-city conversation focused on improving the health of US communities
September 17, 2012
Regulatory Update: GSK announces submission for a new indication for Synflorix™ in Europe
September 13, 2012
GSK to acquire five million shares in Response Genetics for US$1.10 per share in cash
August 24, 2012
GSK and Theravance announce completion of the Phase III programme for once-daily LAMA/LABA (UMEC/VI) in COPD
August 23, 2012
GSK announces start of Phase III programme of sirukumab in rheumatoid arthritis
August 23, 2012
GSK announces start of Phase III programme of sirukumab in rheumatoid arthritis
August 15, 2012
GlaxoSmithKline reaches agreement to divest majority of Classic Brands in Australia for ÂŁ172m
August 08, 2012
GlaxoSmithKline and the American Lung Association join forces to help raise awareness of the impact of asthma in St. Louis
August 03, 2012
GSK Completes Acquisition of Human Genome Sciences
August 03, 2012
Regulatory Update – GSK announces submissions in the EU and US for dabrafenib and trametinib
July 31, 2012
GlaxoSmithKline shipping U.S. flu vaccine with new strain coverage recommended for 2012-2013
July 30, 2012
GSK announces acquisition of 79% of Human Genome Sciences shares; commences subsequent offering period
July 26, 2012
Once-daily dolutegravir is non-inferior to twice-daily raltegravir in treatment-naĂŻve adults with HIV-1
July 25, 2012
Results announcement for the second quarter 2012
July 17, 2012
GlaxoSmithKline and Amicus Therapeutics expand Fabry disease collaboration
July 16, 2012
GSK to acquire Human Genome Sciences for US$14.25 per share in cash
July 13, 2012
GSK and Theravance announce regulatory submissions for FF/VI in the US and Europe
July 12, 2012
US Regulatory Update – Tykerb® (lapatinib)
July 11, 2012
GSK announces positive data from Harmony 8 and completion of clinical registration package for albiglutide in type 2 diabetes
July 11, 2012
Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV
July 02, 2012
GSK and Theravance announce positive results from four pivotal phase III studies for once-daily LAMA/LABA (UMEC/VI) in COPD
June 29, 2012
GSK sets 20 July for expiration of tender offer to acquire Human Genome Sciences
June 27, 2012
GlaxoSmithKline Employees Embark on Long-Term Volunteer Assignments throughout the World
June 18, 2012
Supreme Court rules sales reps exempt from overtime payments under outside sales exemption of Fair Labor Standards Act
June 15, 2012
Stiefel Signs Worldwide Acquisition and License Agreement for alitretinoin
June 15, 2012
GSK continues with tender offer to acquire all outstanding shares of Human Genome Sciences
June 14, 2012
GSK receives FDA approval for MenHibrix
June 09, 2012
GSK announces new 52-week data from phase III study of once-weekly albiglutide in type 2 diabetes
June 08, 2012
GSK extends tender offer for all outstanding shares of Human Genome Sciences
June 07, 2012
GSK and XenoPort receive FDA approval for Horizant® for postherpetic neuralgia
June 04, 2012
GSK presents positive results for investigational BRAF and MEK inhibitors dabrafenib and trametinib at ASCO
June 01, 2012
GSK announces expiration of Hart-Scott-Rodino waiting period for tender offer for HGS
May 30, 2012
Regulatory Update – GSK announces submissions in the EU & US for new indications for Promacta®/Revolade®
May 29, 2012
GlaxoSmithKline confirms US District Court ruling in Pronova BioPharma’s favour on Lovaza™ patents
May 24, 2012
Innovative public-private collaboration launches to tackle antibiotic research
May 21, 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC enter into a co-promotion agreement for TESTIM® in the U.S.
May 17, 2012
GSK statement on tender offer to acquire Human Genome Sciences
May 16, 2012
GlaxoSmithKline completes transaction to increase its ownership in Theravance
May 15, 2012
GlaxoSmithKline to fully acquire Cellzome for ÂŁ61 million
May 11, 2012
Stiefel receives US FDA approval of Fabior™ Foam, 0.1%
May 10, 2012
GSK commences tender offer to acquire Human Genome Sciences for US $13.00 per share in cash
May 09, 2012
GSK to commence tender offer to acquire Human Genome Sciences for US $13.00 per share in cash
May 03, 2012
GlaxoSmithKline plc appoints two Non-Executive Directors to its Board
May 01, 2012
GlaxoSmithKline and Yale University establish drug discovery collaboration to design potential new class of medicines
April 27, 2012
Mayor Nutter Announces $1 Million Grant from GSK and The Philadelphia Foundation for Summer Youth Internships
April 26, 2012
FDA approves Votrient® for treatment of patients with certain types of advanced soft tissue sarcoma
April 26, 2012
GSK and University of Nottingham collaborate to create Centre of Excellence for sustainable chemistry
April 25, 2012
Results announcement for the first quarter 2012
April 20, 2012
GlaxoSmithKline reaches agreement to divest non-core over-the-counter (OTC) brands in international markets for ÂŁ164 million
April 11, 2012
GSK provides update on corporate responsibility commitments in 2011 report
April 04, 2012
GlaxoSmithKline named a Member of America’s Health Insurance Plans (AHIP) 2012 Select Program
April 03, 2012
GSK receives further data from phase lll studies of albiglutide in type 2 diabetes
April 02, 2012
GlaxoSmithKline to increase its ownership in Theravance
April 02, 2012
Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV
March 26, 2012
GSK and Genentech Reach Patent Settlement
March 20, 2012
GSK announces positive vote from FDA panel for pazopanib in certain advanced soft tissue sarcomas
March 20, 2012
New survey reveals lupus communication gap as many patients remain silent on true impact of disease
March 15, 2012
GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands
March 08, 2012
GlaxoSmithKline, Triangle Community Foundation Invite Healthcare Nonprofits to Apply for $40,000 IMPACT Awards
March 06, 2012
GlaxoSmithKline Invites Philadelphia Area and City of Camden Healthcare Nonprofits to Apply for $40,000 IMPACT Awards
March 05, 2012
Regulatory Update: GSK announces submissions for two influenza vaccines
March 01, 2012
GSK and Daiichi Sankyo vaccines joint venture to become largest vaccines company in Japan
February 17, 2012
GlaxoSmithKline receives positive opinion in Europe from the CHMP for Nimenrix®
February 16, 2012
EU and US Regulatory Update – Tykerb/Tyverb® (lapatinib)
February 07, 2012
GSK results announcement for Q4 and full year 2011
January 30, 2012
GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020
January 27, 2012
GSK announces changes to the Board
January 09, 2012
GSK and Theravance announce initial outcomes from pivotal Phase III studies for once-daily RelovairTM* in COPD and asthma
December 20, 2011
GlaxoSmithKline provides update on divestment of non-core over-the-counter (OTC) brands
December 16, 2011
GSK extends pneumococcal vaccine agreement with GAVI Alliance
December 08, 2011
GSK presents phase lll data for lapatinib at San Antonio breast cancer symposium
December 06, 2011
GSK announces changes to the REMS program for PROMACTA® (eltrombopag)
December 01, 2011
Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine
December 01, 2011
Reporting on a core earnings basis will begin with effect from Q1 2012
November 17, 2011
GSK welcomes GAVI Alliance decision to introduce vaccines against cervical cancer and rubella in the world’s poorest countries
November 17, 2011
GlaxoSmithKline welcomes innovative knowledge-sharing collaboration to break deadlock in antibiotic discovery and development
November 16, 2011
GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes
November 07, 2011
GSK presents phase III results for eltrombopag in hepatitis C virus related thrombocytopenia
November 03, 2011
GlaxoSmithKline reaches agreement in principle to resolve multiple investigations with US Government
October 26, 2011
GSK delivers strong Q3 performance with underlying sales growth of 6% and reported sales growth of 3%
October 26, 2011
GSK joins WIPO Re:Search open innovation platform as part of its commitment to tackling diseases of the developing world
September 23, 2011
Regulatory Update: GlaxoSmithKline receives Complete Response letter from FDA for candidate meningococcal and Hib combination vaccine
September 15, 2011
GlaxoSmithKline (GSK) and McLaren Group announce innovative strategic partnership
September 13, 2011
GlaxoSmithKline (GSK) commits $1 million in cervical cancer vaccine to new cooperative effort aimed at reducing deaths from women's cancers
September 12, 2011
GlaxoSmithKline and Amicus Therapeutics commence second phase III study of Amigal™ for Fabry disease
September 12, 2011
GSK gives update on agreement with World Health Organization to support de-worming of school age children in endemic countries
September 09, 2011
Lapatinib clinical trial update
September 07, 2011
Jens Eckstein named President of SR One, GSK’s venture healthcare group
September 06, 2011
GSK awarded contract by BARDA to support research on potential novel antibiotic
August 29, 2011
GlaxoSmithKline joins North Carolina employer coalition to offer medical homes
August 22, 2011
GSK takes minority stake in new spin out Autifony Therapeutics
August 15, 2011
GSK and Impax announce positive topline results of ASCEND-PD Phase III study of IPX066 in Advanced Parkinson’s disease
August 10, 2011
GSK and Enigma Diagnostics announce collaboration on assay development and commercialisation of Enigma’s ML platform
August 09, 2011
Regulatory Update: GSK and XenoPort submit supplemental New Drug Application to FDA for Horizant™ in postherpetic neuralgia
August 03, 2011
Regulatory update – Stiefel, a GSK company, files NDA for tazarotene foam
July 21, 2011
GlaxoSmithKline European regulatory update on Pandemrix™
July 18, 2011
GlaxoSmithKline pledges $10 million at White House meeting on US education reform
July 15, 2011
GlaxoSmithKline begins distribution of flu vaccine to U.S. customers for 2011-2012 flu season
July 14, 2011
GlaxoSmithKline and Human Genome Sciences receive European authorisation for Benlysta® (belimumab)
July 08, 2011
GlaxoSmithKline receives FDA approval for BOOSTRIX to help prevent whooping cough in adults 65 years and older
July 06, 2011
EU and US Regulatory Update - Votrient® (pazopanib)
July 05, 2011
GlaxoSmithKline implements next phase of new incentive compensation program for U.S. sales representatives
July 01, 2011
GlaxoSmithKline receives new approval for Rotarix and significant new indication for Lamictal® (lamotrigine) in Japan
June 28, 2011
GSK welcomes external scientists to diseases of the developing world research campus
June 24, 2011
GSK statement on University of East Anglia study examining health impacts of anticholinergic medicines for over 65s
June 23, 2011
GSK statement on agreements with State Attorneys General on former Cidra manufacturing facility
June 14, 2011
GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
June 13, 2011
GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)
June 09, 2011
GlaxoSmithKline & Liberty/Synterra break ground on Five Crescent Drive at The Philadelphia Navy Yard
June 04, 2011
GlaxoSmithKline’s pazopanib improved progression free survival in adults with certain soft tissue sarcomas
June 02, 2011
GSK and Theravance announce results of two pivotal Phase III studies for Relovair in COPD
May 20, 2011
GlaxoSmithKline and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® (belimumab)
May 19, 2011
GlaxoSmithKline Drug Development seeks more insight into Hispanic health care needs
April 27, 2011
GSK Q1 performance demonstrates continued progress with delivery of underlying sales growth, cash generation and pipeline visibility
April 25, 2011
FDA approves Lamictal®XR™(lamotrigine) for conversion to monotherapy for treatment of partial seizures in appropriate patients
April 21, 2011
New survey finds gap in doctor-patient migraine communication
April 18, 2011
Regulatory update – GSK and Valeant respond to FDA on ezogabine
April 18, 2011
GSK welcomes key agreement to support global preparedness against pandemic influenza
April 15, 2011
Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine
April 15, 2011
Regulatory Update - Tyverb® (lapatinib)
April 14, 2011
GlaxoSmithKline announces non-core OTC products to be divested
April 12, 2011
Unique research alliance expands collaboration opportunities at state-of-the-art medical imaging centre
April 06, 2011
GlaxoSmithKline and XenoPort receive FDA approval for Horizant™
March 31, 2011
GSK publishes payments for research, consulting and advising by US healthcare professionals
March 30, 2011
GlaxoSmithKline confirms Pronova BioPharma reaches agreement with Apotex regarding Lovaza™ US patent litigation
March 28, 2011
GSK publishes 2010 Corporate Responsibility Report
March 24, 2011
GlaxoSmithKline Pledges $5 Million Grant to City of Philadelphia for Youth Development
March 23, 2011
GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
March 18, 2011
GSK supports recovery efforts to help those affected by the Tohoku Kanto earthquake
March 28, 2011
GSK publishes 2010 Corporate Responsibility Report
March 24, 2011
GlaxoSmithKline Pledges $5 Million Grant to City of Philadelphia for Youth Development
March 23, 2011
GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
March 18, 2011
GSK supports recovery efforts to help those affected by the Tohoku Kanto earthquake
March 10, 2011
GSK’s anti-epileptic drug Lamictal® XR™ (lamotrigine) reviewed by FDA advisory committee
March 10, 2011
GlaxoSmithKline establishes dedicated team to support community pharmacists
March 04, 2011
GlaxoSmithKline plc appoints two Non-Executive Directors to its Board
February 25, 2011
FDA grants full approval for PROMACTA® (eltrombopag) for treatment of rare blood disorder
February 25, 2011
David Redfern appointed as new Chairman of ViiV Healthcare
February 16, 2011
GlaxoSmithKline 15th Annual IMPACT Awards seek Philadelphia area and Camden healthcare nonprofits
February 11, 2011
First African country introduces GSK’s pneumococcal vaccine through innovative financing mechanism
February 08, 2011
GlaxoSmithKline moving to new building at Philadelphia Navy Yard
February 07, 2011
GSK revises US Avandia label to include new restrictions on use
February 07, 2011
GlaxoSmithKline and Human Genome Sciences announce publication of BLISS-52 phase lll study results for Benlysta® in The Lancet
February 03, 2011
GSK results announcement for the fourth quarter
February 03, 2011
GSK and Theravance announce progression of LAMA/LABA combination treatment into Phase III development for COPD
February 01, 2011
GSK announces the sale of its entire shareholding in Quest Diagnostics
January 28, 2011
GSK and Actelion discontinue clinical development of almorexant
January 26, 2011
GSK receives FDA Complete Response letter for Avodart for prostate cancer risk reduction supplemental indication
January 24, 2011
Important information for ARIXTRA® Starter Kit patients regarding Triad Group’s alcohol prep products
January 24, 2011
GlaxoSmithKline announces start of two phase III studies in advanced/metastatic melanoma
January 21, 2011
Regulatory update - GSK and Valeant receive positive opinion in Europe from the CHMP for Trobalt (retigabine)
January 19, 2011
GSK and Prosensa announce start of Phase III study of investigational Duchenne Muscular Dystrophy medication
January 19, 2011
GlaxoSmithKline commences Phase III study of intravenous zanamivir for hospitalised patients with influenza
January 17, 2011
GlaxoSmithKline announces Q4 2010 legal charge
January 14, 2011
Information Notice on Stolen Consumer Health Products from GlaxoSmithKline
January 12, 2011
GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK’786, formerly Traficet-EN™, for the treatment of Crohn’s disease
January 10, 2011
HealthCoach4Me, GlaxoSmithKline’s new, virtual health-coaching Website helps consumers reach health and wellness goals
January 07, 2011
GlaxoSmithKline and DENTSPLY International sign global agreement to create a portfolio of co-branded professional oral care products
January 02, 2011
GSK responds to 60 Minutes
December 21, 2010
GlaxoSmithKline and Theravance commence MABA Phase IIb COPD study
December 20, 2010
GSK appoints PHD to manage all US media planning and buying
December 16, 2010
GlaxoSmithKline and Impax Pharmaceuticals enter global agreement to develop and commercialise a late stage compound for Parkinson’s Disease
December 16, 2010
Andrew Witty appointed Lead Non-Executive Board Member for the Department for Business, Innovation and Skills (BIS)
December 13, 2010
GSK to strengthen Nutritional Healthcare business with acquisition of Maxinutrition
December 10, 2010
Phase III study in HER2-positive advanced breast cancer shows overall survival benefit when Tykerb is combined with paclitaxel
December 10, 2010
Data from Tykerb investigational phase III studies in neo-adjuvant HER2-positive breast cancer presented at breast cancer symposium
December 07, 2010
GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals in China
December 03, 2010
GlaxoSmithKline and Human Genome Sciences announce FDA extension of Benlysta® PDUFA target date to 10th March 2011
December 01, 2010
Avodart reviewed by FDA advisory committee for prostate cancer risk reduction
November 29, 2010
Government patent box proposals ‘transform’ UK attractiveness for investment
November 29, 2010
GlaxoSmithKline to increase its shareholding in Theravance
November 26, 2010
GlaxoSmithKline and JSC Binnopharm enter vaccine production alliance in Russia
November 23, 2010
GlaxoSmithKline and Dr Reddy’s agree to the sale of US penicillin facility and products
November 22, 2010
GSK statement on dismissal of Paxil product liability trial in Philadelphia Court of Common pleas
November 17, 2010
COPD patients reveal disease progression leads to physical and social isolation and increased reliance on the internet
November 16, 2010
Human Genome Sciences and GlaxoSmithKline announce vote of FDA advisory committee to recommend approval of Benlysta® for systemic lupus erythematosus
November 15, 2010
New study findings show no benefit of prescription omega-3 fatty acids in prevention of recurrent symptomatic atrial fibrillation in affected patients
November 12, 2010
GlaxoSmithKline and Fiocruz extend innovative collaboration to research and develop new medicines for neglected tropical diseases
November 05, 2010
GlaxoSmithKline and XenoPort respond to FDA on Horizant™ for RLS
October 29, 2010
GlaxoSmithKline receives approval in Japan for two medicines: Revolade and Xyzal
October 29, 2010
GSK and Amicus Therapeutics enter exclusive worldwide agreement to develop and commercialise Amigal™ for Fabry disease
October 28, 2010
GlaxoSmithKline Consumer Healthcare Begins Installation of North America’s Largest Rooftop Solar Array
October 26, 2010
GSK completes previously reported settlement with U.S. Department of Justice regarding former manufacturing plant
October 22, 2010
CorePharma and GlaxoSmithKline conclude agreement on US rights for Dexedrine®, Albenza® and Daraprim®
October 21, 2010
GSK announces Q3 results for 2010
October 18, 2010
GSK outlines approach to delivering advances in the treatment of rare diseases
October 18, 2010
GSK, Fondazione Telethon and Fondazione San Raffaele to collaborate on gene therapy for rare diseases
October 14, 2010
GSK increases support for WHO strategy to improve children’s health with new 5-year commitment to expand donations of albendazole medicine
October 12, 2010
Stiefel, a GSK company, receives FDA approval of SORILUX™ (calcipotriene) Foam, 0.005%
October 04, 2010
GSK takes minority stake in newly formed Convergence Pharmaceuticals
October 01, 2010
GSK maintains perfect score for corporate equality from Human Rights Campaign
September 30, 2010
GSK provides update on Herpevac trial for women evaluating Simplirix™ (Herpes Simplex Vaccine)
September 30, 2010
A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
September 29, 2010
Soccer champion Mia Hamm teams with GSK to encourage adults to “Give Your Health A Shot”
September 23, 2010
GSK regulatory update on Avandia following EMA and FDA reviews
September 22, 2010
GSK and Theravance announce combination ICS/LABA Phase II results in the Relovair™ development programme
September 16, 2010
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
September 15, 2010
Three-year results from ECLIPSE study indicate that COPD patients may require prevention strategies to manage exacerbations, regardless of disease severity
September 11, 2010
GSK and BJD collaborate on a new educational programme to reduce global burden of joint pain
September 08, 2010
GlaxoSmithKline and Genmab announce start of ofatumumab Phase III combination study in non-Hodgkin’s lymphoma
September 08, 2010
GSK announces succession plan for Chief Financial Officer
September 08, 2010
Galapagos reaches agreement to acquire GlaxoSmithKline research centre in Zagreb, Croatia
September 08, 2010
GSK signs agreement with Lonza to secure capacity and expertise in biological manufacturing to support ongoing development of GSK’s biopharmaceuticals portfolio
August 30, 2010
GSK and Valeant announce new U.S. FDA PDUFA goal date for ezogabine
August 23, 2010
GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles
August 11, 2010
Ezogabine, an investigational anti-epileptic drug, receives positive vote from FDA advisory committee
August 05, 2010
Image of new antibiotic in action opens up new opportunities to combat antibacterial resistance
July 30, 2010
GlaxoSmithKline begins distribution of flu vaccine to U.S. customers for 2010-2011 flu season
July 29, 2010
GSK exercises option on Anacor’s novel antibiotic for the treatment of gram-negative infections
July 26, 2010
GlaxoSmithKline to Implement New Compensation Program for U.S. Sales Professionals
July 21, 2010
GlaxoSmithKline statement in response to FDA announcement on TIDE trial
July 21, 2010
GSK announces Q2 results for 2010
July 16, 2010
Update to 2009 Notification of Stolen Advair Diskus Inhalers
July 16, 2010
Stiefel, a GSK company, Receives FDA Approval of VELTIN™ (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%
July 15, 2010
GlaxoSmithKline legal update
July 14, 2010
GlaxoSmithKline statement in response to FDA Advisory Committees’ vote on safety of Avandia® (rosiglitazone)
July 14, 2010
Information Notice on Certain Stolen Consumer Health Products from GlaxoSmithKline
July 13, 2010
GlaxoSmithKline (GSK) responds to Senate Finance Committee letter of 12 July to FDA
July 09, 2010
Data support Avandia (rosiglitazone maleate) cardiovascular safety profile
July 01, 2010
BC and Goody’s online “Pick A Powder” contest kicks off starring Trace Adkins and Richard Petty
July 01, 2010
GSK and Aptuit finalise agreement for Aptuit to acquire GSK’s research operations in Italy
June 23, 2010
GlaxoSmithKline enters agreement with Medivir for exclusive rights to cold sore treatment Xerclear™
June 18, 2010
FDA approves STAXYN™ (vardenafil HCl) orally disintegrating tablets for erectile dysfunction (ED)
June 11, 2010
GlaxoSmithKline Receives Complete Response from FDA for Candidate Meningococcal and Hib Combination Vaccine
June 10, 2010
GSK drives Latin America growth strategy with acquisition of Laboratorios Phoenix
June 10, 2010
Regulatory update – BLA filed for Benlysta® (belimumab)
June 02, 2010
GSK announces revised product labels for Serevent and Advair
May 26, 2010
GSK Consumer Healthcare to update alli label as FDA completes safety review of orlistat
May 19, 2010
New research identifies promising leads to follow in search for medicines to fight malaria
May 14, 2010
FDA says Healthcare Providers can resume use of Rotarix (Rotavirus Vaccine, Live, Oral)
May 11, 2010
Patrick Vallance appointed to GSK executive leadership team
May 11, 2010
GSK extends presence in Asia with new strategic alliance in South Korea
May 07, 2010
GSK Statement on FDA Advisory Committee Meeting on Rotavirus Vaccines
May 04, 2010
New survey shows families may not be addressing their oral health care needs
April 28, 2010
GSK announces Q1 results for 2010
April 27, 2010
New Nicorette mini lozenge offers convenient, pocket-sized support to help smokers looking to quit
April 13, 2010
GlaxoSmithKline honors healthcare nonprofits with $360,000 in awards
March 31, 2010
GSK and Isis Pharmaceuticals collaborate on RNA therapeutics for rare and infectious diseases
March 29, 2010
GSK regulatory update – Avodart (dutasteride)
March 29, 2010
GSK offers free vaccines to uninsured adults
March 26, 2010
Updated GlaxoSmithKline statement on European regulatory guidance relating to manufacture of Rotarix (rotavirus vaccine)
March 23, 2010
GSK responds to JAMA editorial and commentary
March 22, 2010
GlaxoSmithKline statement on new information relating to manufacture of Rotarix (rotavirus vaccine)
March 22, 2010
GSK announces succession plan for leadership of Consumer Healthcare business
March 19, 2010
GlaxoSmithKline commences Relovair Phase III asthma programme
March 16, 2010
GSK publishes 2009 Corporate Responsibility Report
March 15, 2010
Reminder: GlaxoSmithKline 14th Annual IMPACT awards application deadline March 29, 2010
March 12, 2010
GSK commences succession plan for management of vaccines business
March 08, 2010
GSK CEO Andrew Witty dedicates albendazole facility in Nashik to WHO’s Global Programme to Eliminate LF
February 24, 2010
GlaxoSmithKline responds to US Senate Committee on Finance report on Avandia
February 24, 2010
Information notice on certain stolen pharmaceutical and consumer health products from GlaxoSmithKline
February 20, 2010
GSK rejects conclusions of Senate Committee on Finance Staff Report on Avandia
February 20, 2010
GSK rejects conclusions reported in The New York Times story on Avandia
February 18, 2010
GSK statement on FDA’s proposed label revisions for some asthma medicines
February 18, 2010
GSK Consumer Healthcare warns consumers of potential health risks associated with long-term excessive use of zinc-containing denture adhesives
February 17, 2010
GlaxoSmithKline and XenoPort receive FDA Complete Response letter for Horizant™ (GSK1838262/XP13512) for RLS
February 10, 2010
GlaxoSmithKline introduces CARES by GSK to improve patient access to GSK oncology and specialty medicines
February 04, 2010
GSK launches new specialist unit to research and develop medicines for rare diseases
February 04, 2010
GSK announces appointment of Philippe Fauchet as President of GSK Japan
February 04, 2010
Results announcement for the fourth quarter 2009
February 02, 2010
Make the big game healthy and heartburn free
January 29, 2010
GSK’s TYKERB receives accelerated approval for first-line combination treatment of metastatic breast cancer
January 29, 2010
FDA approves once-a-day LamictalXR as add-on epilepsy therapy for primary generalized tonic-clonic seizures
January 26, 2010
GlaxoSmithKline grants $360,000 to nine healthcare nonprofits – each to receive $40,000
January 20, 2010
GSK announces ‘open innovation’ strategy to help deliver new and better medicines for people living in the world’s poorest countries
January 18, 2010
GSK contributes to Haiti relief efforts
January 15, 2010
GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine
January 13, 2010
Eight in 10 Americans say they’re in control of their eating habits – but growing obesity crisis tells another story
January 12, 2010
GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine
December 16, 2009
GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
December 14, 2009
GSK publishes speaking, consulting fees paid to US healthcare professionals
December 11, 2009
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
December 11, 2009
GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
December 09, 2009
GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib
December 08, 2009
Long-term Bexxar® data demonstrate overall survival
December 08, 2009
Stop-smoking gum launches new campaign showing smokers how quitting can “Suck Less”
December 01, 2009
GSK Update: GSK’s Arepanrix™ H1N1 pandemic vaccine prequalified by the World Health Organization
December 01, 2009
GSK completes extension of strategic collaboration with Aspen
November 30, 2009
GlaxoSmithKline establishes $1 million scholarship fund at The Philadelphia Foundation
November 30, 2009
GlaxoSmithKline announced as Tier 3 Sponsor as London 2012 anti-doping plans confirmed
November 30, 2009
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
November 24, 2009
GlaxoSmithKline and Gilead announce agreement to commercialise Viread® for chronic hepatitis B in key Asian countries
November 23, 2009
GSK Regulatory Update: Avodart
November 23, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data in children and adolescents from 3 to 17 years of age
November 16, 2009
GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction
November 10, 2009
Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccine
November 10, 2009
GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries
November 09, 2009
GlaxoSmithKline and XenoPort announce extension of GSK1838262 (XP13512) FDA review date to 9 February, 2010
November 09, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)
November 06, 2009
World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine
November 05, 2009
Nine area healthcare nonprofits win $40,000 each in funding from GlaxoSmithKline in partnership with the Triangle Community Foundation
November 03, 2009
World’s largest malaria vaccine trial now underway in seven African countries
November 03, 2009
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care
November 02, 2009
Retigabine Regulatory Update
November 02, 2009
GlaxoSmithKline and Human Genome Sciences announce positive results in second of two phase 3 trials of Benlysta in systemic lupus erythematosus
October 28, 2009
Results announcement for the third quarter 2009
October 27, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data in an elderly population
October 27, 2009
GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD
October 26, 2009
GSK and Genmab receive accelerated approval for Arzerra™
October 23, 2009
Pandemic (H1N1) 2009 Influenza Update: Experience of GSK’s H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results
October 21, 2009
CDC Advisory Committee recommends Cervarix to prevent cervical cancer in girls and young women
October 19, 2009
FDA approves GlaxoSmithKline’s Votrient™ for advanced renal cell cancer
October 16, 2009
FDA approves Cervarix, GlaxoSmithKline’s cervical cancer vaccine
October 16, 2009
GSK’s Cervarix® becomes the first cervical cancer vaccine to gain approval in Japan
October 13, 2009
GSK Statement on Jury Verdict in Paxil Product Liability Trial in Philadelphia Court of Common Pleas
October 13, 2009
GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
October 13, 2009
GSK partners with UK Government and Wellcome Trust to stimulate innovation through the creation of a world-class science park
October 12, 2009
GSK’s Avodart® / tamsulosin combination showed benefits for men with prostate enlargement
October 08, 2009
GlaxoSmithKline and U.S. Patent and Trademark Office file a motion to dismiss litigation over Final Regulations
October 06, 2009
GSK expands presence in China through strategic cooperation to form a joint venture on paediatric vaccines
October 06, 2009
GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine
October 01, 2009
GlaxoSmithKline applauds compassion, competence, passion and perseverance in North Carolina’s child advocates
October 01, 2009
Avodart (dutasteride) Regulatory Update
September 30, 2009
Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives European Commission Approval
September 29, 2009
GlaxoSmithKline Update on FDA Review of Cervarix
September 28, 2009
GSK provides update on regulatory filings for Zunrisa/Rezonic
September 25, 2009
Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives positive opinion from European Regulators
September 22, 2009
GlaxoSmithKline named a 2009 100 Best Company By Working Mother Magazine
September 22, 2009
GlaxoSmithKline Receives Perfect Score on Corporate Equality Index
September 21, 2009
GSK limits medical education funding to independent programs with highest impact on patient care
September 17, 2009
Positive phase IIb results for GSK1838262 (XP13512) reported for neuropathic pain associated with post-herpetic neuralgia
September 16, 2009
GSK makes it easier for unemployed, uninsured to get free medicines
September 14, 2009
Pandemic (H1N1) 2009 Influenza Update: Initial results from first clinical trial of GSK’s H1N1 adjuvanted vaccine
September 10, 2009
GSK named to AARP list of 2009 Best Employers for Workers Over 50
September 09, 2009
FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKline’s candidate cervical cancer vaccine
September 08, 2009
New gel technology reaches hidden areas of the mouth
September 02, 2009
FDA states consumers should continue to use alli
August 25, 2009
GSK advisory: Warehouse theft
August 19, 2009
FDA approves GSK's HIB vaccine, Hiberix®
August 17, 2009
GlaxoSmithKline and Genmab announce results from a study of Arzerra in rituximab refractory follicular NHL
August 17, 2009
GSK and Brazil’s Fiocruz form partnership for new R&D effort and increased vaccine access
August 14, 2009
Pandemic (H1N1) 2009 influenza update
August 04, 2009
GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine
July 29, 2009
GlaxoSmithKline and Genmab announce top-line results for ofatumumab in rheumatoid arthritis
July 29, 2009
Regulatory update: mepolizumab for the treatment of hypereosinophilic syndrome (HES)
July 27, 2009
Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis (PMO)
July 22, 2009
GlaxoSmithKline completes acquisition of Stiefel
July 22, 2009
Results announcement for the second quarter 2009
July 22, 2009
Pandemic (H1N1) 2009 Influenza Update
July 21, 2009
GSK and Enigma Diagnostics announce commercial partnership to develop point-of-care influenza diagnostics
July 20, 2009
GlaxoSmithKline, Morehead offer "Science in the Summer"
July 08, 2009
Alnylam joins GSK in donating intellectual property to patent pool for neglected tropical diseases
July 07, 2009
Landmark study for GSK’s cervical cancer vaccine published in The Lancet
July 02, 2009
GSK further extends its product portfolio in the Middle East and North Africa
June 23, 2009
Regulatory update for REZONIC™ (casopitant mesylate)
June 16, 2009
FDA extends review of Arzerra™ (ofatumumab)
June 15, 2009
GSK announces a strategic alliance with Dr. Reddy’s to further accelerate sales growth in emerging markets
June 12, 2009
GlaxoSmithKline update: A (H1N1) influenza
June 09, 2009
GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China
June 03, 2009
GSK donates $100,000 to support breast health outreach
June 02, 2009
GSK and Concert Pharmaceuticals form alliance to develop novel deuterium-modified drugs
June 01, 2009
GSK’s Pazopanib significantly delayed tumor progression in patients with advanced kidney cancer
June 01, 2009
FDA approves Lamictal®XR™; an extended-release once-daily, new generation treatment for epilepsy
May 29, 2009
FDA advisory panel makes favorable recommendation for ARZERRA (ofatumumab)
May 15, 2009
GlaxoSmithKline update: A (H1N1) influenza vaccine development
May 13, 2009
FDA Advisory Committee Meeting for GSK’s Rezonic® Cancelled
May 13, 2009
Research findings on nine GlaxoSmithKline cancer compounds to be presented at ASCO 2009
May 12, 2009
GSK extends strategic collaboration with Aspen
May 11, 2009
FDA approves Lamictal® ODT™ Orally Disintegrating Tablets
May 08, 2009
New data for GlaxoSmithKline’s vaccine, Cervarix®, presented at IPV Conference
May 06, 2009
GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million
May 01, 2009
GlaxoSmithKline update: influenza A (H1N1)
April 27, 2009
Large, long-term study shows dutasteride reduced prostate cancer risk in men at increased risk of the disease
April 27, 2009
Emergence of a new H1N1 influenza A strain (swine influenza)
April 27, 2009
Phase II results for GSK1838262 (XP13512) reported for neuropathic pain associated with diabetic peripheral neuropathy
April 20, 2009
GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business
April 16, 2009
GlaxoSmithKline and Pfizer announce innovative agreement to create a new world-leading, specialist HIV company
April 09, 2009
Diabetes Ten City Challenge reduces health care costs and improves patient health
April 08, 2009
Heartburn sufferers find lasting relief with TUMS® dual action
April 01, 2009
GSK submits Tyverb®/Tykerb® (lapatinib) for first-line treatment of metastatic breast cancer in Europe, US
March 31, 2009
Federal cigarette tax increase and current economy will change smoker’s habits
March 30, 2009
Cervarix® U.S. regulatory update
March 25, 2009
GlaxoSmithKline global collaboration identifies two new genes for COPD
March 19, 2009
GlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.
March 19, 2009
GSK sponsored prescription savings program, Together Rx Access, expands eligibility criteria
March 17, 2009
GlaxoSmithKline awards ten healthcare nonprofits with $40,000 each in funding
March 12, 2009
Wynonna Judd and alli to host private concert
March 11, 2009
Prasco selected as GSK’s generics marketing and distribution agent
March 10, 2009
GSK Consumer Healthcare helps to bridge oral care gap in Appalachia
March 04, 2009
GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer
March 02, 2009
Ample supplies of Relenza available as flu season peaks
February 25, 2009
Wynonna Judd and alli hit the road for a healthier America
February 17, 2009
GSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide)
February 06, 2009
GlaxoSmithKline and Idenix Pharmaceuticals sign worldwide license agreement for IDX899, a novel NNRTI for the treatment of HIV
February 05, 2009
GlaxoSmithKline and Genmab seek European marketing authorisation of Arzerra™ (ofatumumab) in advanced stage blood cancer
February 05, 2009
Results announcement for the fourth quarter 2008
February 04, 2009
GSK and Theravance announce positive phase 2b results for once-daily fluticasone furoate in the treatment of asthma
February 02, 2009
GlaxoSmithKline plc, announces board changes
January 30, 2009
GlaxoSmithKline and Genmab submit Arzerra (Ofatumumab) application to FDA for the treatment of advanced stage blood cancer
January 30, 2009
Deirdre Connelly to join GSK as President, North American Pharmaceuticals
January 29, 2009
GSK announces charges for legal matters
January 29, 2009
The UK Government signs influenza pandemic contract with GlaxoSmithKline for Relenza®
January 19, 2009
GlaxoSmithKline awards ten area healthcare nonprofits with $40,000 each in funding
January 09, 2009
GSK and Xenoport resubmit new drug application for Solzira™ in restless legs syndrome
January 07, 2009
Wynonna Judd reveals her alli®, her story for finding a healthier lifestyle
To download PDF files you will need Adobe Reader. If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.
For audio-visual content you can use either Windows Media Player or Real Player, which can be installed free from their respective websites.
